VACCINE STUDY

BLAZE-2

CERID Circles_Grey-03.png





Coronavirus

COVID-19 Studies

Blaze-2
 

Blaze-2 was created in partnership with NIAID and Eli Lilly to focus on the prevention of COVID-19, specifically in nursing and assisted living facilities.

This medical research study evaluates an investigational vaccine for the prevention of COVID-19 involving the Johnson & Johnson/Janssen vaccine.

This clinic evaluates the short- and long-term health consequences of COVID-19 for patients previously diagnosed with the infection.

Burden of COVID-19 in Kentuckiana

Define the incidence, epidemiology, and clinical outcomes of patients with COVID-19 in Louisville, Kentucky and southern Indiana.

The primary level of proliferation of COVID-19 directly impacts Healthcare Workers. Interventions could be embedded as the pandemic continues.

CoVO was created in 2020, with the goal of facilitating international research in response to the SARS-CoV-2 global pandemic.

UofL Infectious Diseases Biorepository

Developed for the discovery of pathogens and biomarkers, the biorepository now includes specimens and data support for COVID-19.